The target hemoglobin content values of reticulocytes for efficient anemia improvement are achieved by low ferritin levels and moderate transferrin saturation: a retrospective observational study, Chie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, Katsunori Shimada, Fumiyoshi Kanda, Kunimi Maeda, Hematology (Amsterdam, Netherlands), 25:71-78, 2020年12月
Optimizing hepcidin measurement with a proficiency test framework and standardization improvement, Ellis T Aune, Laura E Diepeveen, Coby M Laarakkers, Siem Klaver, Andrew E Armitage, Sukhvinder Bansal, Michael Chen, Marianne Fillet, Huiling Han, Matthias Herkert, Outi Itkonen, Daan van de Kerkhof, Aleksandra Krygier, Thibaud Lefebvre, Peter Neyer, Markus Rieke, Naohisa Tomosugi, Cas W Weykamp, Dorine W Swinkels, Clinical chemistry and laboratory medicine, 59:315-323, 2020年10月
A Hypoxia-Inducible Factor Stabilizer Improves Hematopoiesis and Iron Metabolism Early after Administration to Treat Anemia in Hemodialysis Patients, Chie Ogawa, Ken Tsuchiya, Naohisa Tomosugi, Kunimi Maeda, International journal of molecular sciences, 21:7153, 2020年09月
Effect of cholecalciferol on serum hepcidin and parameters of anaemia and CKD-MBD among haemodialysis patients: a randomized clinical trial, Yoshitsugu Obi, Satoshi Yamaguchi, Takayuki Hamano, Yusuke Sakaguchi, Akihiro Shimomura, Tomoko Namba-Hamano, Satoshi Mikami, Osamu Nishi, Motoko Tanaka, Akihito Kamoto, Yasue Obi, Naohisa Tomosugi, Yoshiharu Tsubakihara, Yoshitaka Isaka, Scientific reports, 10:15500, 2020年09月
Tips for erythropoiesis-stimulating agent treatment of renal anemia, Naohisa Tomosugi, Yoshitaka Koshino, Clinical and experimental nephrology, 24:105-106, 2020年01月
Immuno-detection of mRNA-binding protein complex in human cells under transmission electron microscopy, Qingfeng Ma, Takanori Tatsuno, Yuka Nakamura, Shin-Ichi Izumi, Naohisa Tomosugi, Yasuhito Ishigaki, MICROSCOPY RESEARCH AND TECHNIQUE, 82:680-688, 2019年06月
GLCCI1 is a novel protector against glucocorticoid-induced apoptosis in T cells, (Zentaro Kiuchi), YukinoNishibori, Satoru Kutsuna, Masashi Kotani, Ichiro Hada, Toru Kimura, Toshiyuki Fukutomi, Daisuke Fukuhara, Noriko Ito-Nitta, Akihiko Kudo, Takanobu Takata, Yasuhito Ishigaki, Naohisa Tomosugi, Hirotoshi Tanaka, Satsuki Matsushima, Shinya Ogasawara, Yoshiaki Hirayama, Hiromu Takematsu, Kunimasa Yan, FASEB JOURNAL, 33:7387-7402, 2019年06月
Effect of Collagen Tripeptide on Atherosclerosis in Healthy Humans., N.Tomosugi, S.Yamamoto, M.Takeuchi, H.Yonekura, Y.Ishigaki, N.Numata, S.Katsuda, Y.Sakai, Journal of atherosclerosis and thrombosis, 24:530-538, 2017年05月
Effect of Collagen Tripeptide on Atherosclerosis in Healthy Humans, Naohisa Tomosugi, Shoko Yamamoto, Masayoshi Takeuchi, Hideto Yonekura, Yasuhito Ishigaki, Noriaki Numata, Shogo Katsuda, Yasuo Sakai, Journal of Atherosclerosis and Thrombosis, 24:530-538, 2017年05月
High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation., (S.Sakamoto), H.Kawabata, J.Kanda, T.Uchiyama, C.Mizumoto, T.Kitano, T.Kondo, M.Hishizawa, N.Tomosugi, A.Takaori-Kondo, Cancer medicine, 6:120-128, 2017年01月
A Novel Phenotype of a Hereditary Hemochromatosis Type 4 with Ferroportin-1 Mutation, Presenting with Juvenile Cataracts, N.Yamakawa, K.Oe, N.Yukawa, K.Murakami, R.Nakashima, Y.Imura, H.Yoshifuji, K.Ohmura, Y.Miura, N.Tomosugi, H.Kawabata, A.Takaori-Kondo, T.Mimori, Internal medicine, 55:2697-2701, 2016年09月
Toward Worldwide Hepcidin Assay Harmonization: Identification of a Commutable Secondary Reference Material, van der Vorm LN, Hendriks JC, Laarakkers CM, Klaver S, Armitage AE, Bamberg A, Geurts-Moespot AJ, Girelli D, Herkert M, Itkonen O, Konrad RJ, Tomosugi N, Westerman M, Bansal SS, Campostrini N, Drakesmith H, Fillet M, Olbina G, Pasricha SR, Pitts KR, Sloan JH, Tagliaro F, Weykamp CW, Swinkels DW, Clinical chemistry, 62:993-1001, 2016年03月
Associations among Erythroferrone and Biomarkers of Erythropoiesis and Iron Metabolism, and Treatment with Long-Term Erythropoiesis-Stimulating Agents in Patients on Hemodialysis, H.Honda , Y.Kobayashi, S.Onuma, K.Shibagaki, T.Yuza, K.Hirao, T. Yamamoto, N.Tomosugi, T.Shibata, PLoS One, 11:e0151601, 2016年03月
抗がん剤により膵癌細胞に誘導されるEMT促進因子の同定と機能解析, 島崎猛夫, 山本聡子, 石垣靖人, 高田尊信, 有沢富康, 元雄良治, 友杉直久, 源 利成, 膵臓, 31:76-84, 2016年
Regulation of soluble Flt-1(VEGFR-1) production by hnRNP D and protein arginine methylation, T.Ikeda, Y.Yoshitomi, H.Saito, T.Shimasaki, H.Yamaya, T.Kobata, Y.Ishigaki, N.Tomosugi, Y.Yoshitake, H.Yonekura, Molecular and Cellular Biochemistry, 413:155-164, 2016年
Nonsense-mediated mRNA decay factor Upf2 exists in both the nucleoplasm and the cytoplasm., T.Tatsuno, Y.Nakamura, Ma Shaofu, N.Tomosugi, Y.Ishigaki, Molecular medicine reports, 14:655-660, 2016年
Phosphorylation status of human RNA-binding protein 8A in cells and its inhibitory regulation by Magoh, Y.Ishigaki, Y.Nakamura, T.Tatsuno, S.Ma, N.Tomosugi, Experimental Biology and Medicine, 240:438-445, 2015年
Effect of saikokeishito, a kampo medicine, on hydrogen peroxide-induced premature senescence of normal human dermal fibroblasts, T. Takata, Y. Motoo, N. Tomosugi, Journal of integrative medicine., 12:495-503, 2014年11月
鉄静注療法と不安定鉄, 友杉直久, 柴田央恵, 日本透析医会雑誌, 29:232-238, 2014年08月
血液透析患者の貧血治療における最少至適フェリチン値とrHuEPO反応性の検討 EPOCHStudy, (望月隆弘), 丹治知恵, 碓井公治, 庄司繁市, 四宮敏彦, 稲葉雅章, 友杉直久, 日本透析医学会雑誌, 47:313-321, 2014年05月
血液透析患者に対する経口鉄剤投与によるhepcidin-25の推移に関する検討, (高澤和也), 高枝知香子, 上田典司, 前田貞亮, 友杉直久, 日本透析医学会雑誌, 47（Suppl.1)：769, 2014年05月
血液透析患者における長時間作動型ESAと鉄代謝について, (大沼聖子), 本田浩一, 道端哲郎, 柴垣圭吾, 油座利貴, 平尾圭市, 友杉直久, 柴田孝則, 日本透析医学会雑誌, 47（Suppl.1)：618, 2014年05月
Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism., (H.Kitade), T.Shimasaki, S.Igarashi, H.Sakuma, M.Mori, N.Tomosugi, M.Nakai, Oncology letters, 7:1499-1502, 2014年05月
鉄代謝とヘプシジン, 友杉直久, 医学検査, 2.652777778, 2014年04月
Regulation of hepcidin-25 by short- and long-acting rhEPO may be dependent on ferritin and predict the response to rhEPO in hemodialysis patients., (K.Takasawa), N.Tomosugi, C.Takaeda, T.Maeda, N.Ueda, Nephron extra [electronic resource], 4:55-63, 2014年04月
慢性腎臓病と鉄代謝：ヘプシジン-25からの視点, 友杉直久, 臨床化学, 43:25-32, 2014年01月
アルコール性肝障害患者にみられる鉄過剰の肝病態への関与と原因としてのhepcidinの発現動態の検討, (藤田尚己), 宮地洋英, 杉本龍亮, 諸岡留美, 田中秀明, 岩佐元雄, 竹井謙之, 山添尚久, 坂 保寛, 原田雅典, 友杉直久, アルコールと医学生物学, 32:19-23, 2014年01月
Comparative evaluation of the effects of treatment with tocilizumab and TNF-α inhibitors on serum hepcidin, anemia response and disease activity in rheumatoid arthritis patients., (SNJ.Song), M.Iwahashi, N.Tomosugi, K.Uno, J.Yamana, S.Yamana, T.Isobe, H.Ito, H.Kawabata, K.Yoshizaki, Arthritis research & therapy., 15:R141;1-10, 2013年10月
A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease., (T.Fujiwara), T.Ikeda, Y.Nagasaka, Y.Okitsu, Y.Katsuoka, N.Fukuhara, Y.Onishi, K.Ishizawa, R.Ichinohasama, N.Tomosugi, H.Harigae, PloS one, 8:e75568;1-13, 2013年09月
Serum ferritin levels adversely affect cardiac function in patients with ST-elevation myocardial infarction who underwent successful percutaneous coronary intervention., (T.Suzuki), K.Toba, K.Kato, T.Ozawa, M.Higasimura, T.Kitajima, H.Oda, K.Tsuchida, N.Tomosugi, H.Saitoh, Y.Aizawa, International journal of cardiology, 167:286-288, 2013年07月
Inhibition of mTORC2 but not mTORC1 up-regulates E-cadherin expression and inhibits cell motility by blocking HIF-2α expression in human renal cell carcinoma., (S.Maru), Y.Ishigaki, N.Shinohara, T.Takata, N.Tomosugi, K.Nonomura, The Journal of urology., 189:1921-1929., 2013年05月
Greater potency of darbepoetin-α than erythropoietin in suppression of serum hepcidin-25 and utilization of iron for erythropoiesis in hemodialysis patients., (S.Shoji), M.Inaba, N.Tomosugi, S.Okuno, M.Ichii, T.Yamakawa, S.Kurihara, European journal of haematology., 90:237-244, 2013年03月
Depletion of RNA-binding protein RBM8A (Y14) causes cell cycle deficiency and apoptosis in human cells., Y.Ishigaki, Y.Nakamura, T.Tatsuno, M.Hashimoto, T.Shimasaki, K.Iwabuchi, N.Tomosugi, Experimental biology and medicine (Maywood, N.J.), 238:889-897, 2013年
Characterization of proteins secreted by pancreatic cancer cells with anticancer drug treatment in vitro, T.Takata, Y.Ishigaki, T.Shimasaki, H.Tsuchida, Y.Motoo, A.Hayashi, N.Tomosugi, Oncology reports., 28:1968-1976, 2012年12月
Effects of erythropoietin administration on iron status in patients with ST-elevation myocardial infarction who underwent successful percutaneous coronary intervention., (T.Suzuki), K.Toba, K.Kato, T.Ozawa, H.Suzuki, N.Tomosugi, H.Saitoh, Y.Aizawa, International journal of cardiology, 167:1644-1645, 2012年11月
Expression pattern of Galectin 4 in rat placentation, Tomohiro Arikawa, Eriko Simamura, Hiroki Shimada, Nozomu Nishi, Takanori Tatsuno, Yasuhito Ishigaki, Naohisa Tomosugi, Chizu Yamashiro, Toshiyuki Hata, Tsutomu Takegami, Tomonori Nakamura, Haruta Mogami, Ken Yamaguchi, Hiroki Otani, Toshihisa Hatta, Hiroki Shoji, Placenta, 2012 Aug 6. [Epub ahead of print], 2012年08月
Expression pattern of Galectin 4 in rat placentation, T.Arikawa, E.Shimamura, H.Shimada, N.Nishi, T.Tatsuno, Y.Ishigaki, N.Tomosugi, C.Yamashiro, T.Hata, T.Takegami, H.Mogami, K.Yamaguchi, T.Nakamura, H.Otani, T.Hatta, H.Shoji, Placenta, 33:885-887, 2012年08月
Hepcidin expression in iron overload diseases is variably modulated by circulating factors., (R.Giulia), S.Pelucchi, R.Mariani, N.Tomosugi, G.L.Modignani, M.Pozzi, E.Nemeth, T.Ganz, H.Hayashi, D.Barisani, A.Piperno, PloS one, 7:e36425, 2012年05月
Comparative study of hydrophilic and hydrophobic ionic liquids for observing cultured human cells by scanning electron microscopy., Y.Ishigaki, Y.Nakamura, T.Takehara, T.Kurihara, H.Koga, T.Takegami, H.Nakagawa, N.Nemoto, N.Tomosugi, S.Kuwabata, S.Miyazawa, Microscopy research and technique, 74:1104-1108, 2011年12月
Ultraviolet B-induced expression of amphiregulin and growth differentiation factor 15 in human lens epithelial cells, H.Osada, Y.Yoshitake, T.Ikeda, Y.Ishigaki, T.Takata, N.Tomosugi, H.Sasaki, H.Yonekura, Molecular vision, 17:159-169, 2011年01月
Scanning electron microscopy with an ionic liquid reveals the loss of mitotic protrusions of cells during the epithelial-mesenchymal transition, Y.Ishigaki, Y.Nakamura, T.Takehara, T.Shimasaki, T.Tatsuno, F.Takano, Y.Ueda, Y.Motoo, T.Takegami, H.Nakagawa, S.Kuwabata, N.Nemoto, N.Tomosugi, S.Miyazawa, Microscopy research and technique, 74:1024-1031, 2011年
Ultrastructural localization of Upf2 and its binding to mRNA molecules in human cells, Y.Ishigaki, T.Kurihara, Y.Nakamura, X.Zhao, T.Takata, S.Izumi, T.Takegami, N.Tomosugi, H.Nakagawa, 医学生物学電子顕微鏡技術学会誌, 24:8-13, 2010年11月
慢性移植腎障害に対する脂質およびアディポネクチンの検討, 足立浩樹, 木村庄吾, 渥美浩克, 井村淳子, 山谷秀喜, 浅香充宏, 友杉直久, 横山 仁, Therapeutic Research, 31:1225-1230, 2010年10月
Increased hepcidin production impairs iron metabolism after pancreatoduodenectomy, (T.Kosuge), T.Sawada, M.Shimoda, J.Kita, N.Tomosugi, K.Kubota, World journal of surgery, 34:2452-2456, 2010年10月
Ionic liquid enables simple and rapid sample preparation of human culturing cells for scanning electron microscope analysis, Y.Ishigaki, Y.Nakamura, T.Takehara, N.Nemoto, T.Kurihara, H.Koga, H.Nakagawa, T.Takegami, N.Tomosugi, S.Miyazawa, S.Kuwabata, Microscopy research and technique, 74:415-420, 2010年09月
Patients with chronic hepatitis C may be more sensitive to iron hepatotoxicity than patients with HFE-hemochromatosis, (H.Hayashi), A.Piperno, N.Tomosugi, K.Hayashi, F.Kimura, S.Wakusawa, M.Yano, Y.Tatsumi, A.Hattori, S.Pelucchi, Y.Katano, H.Goto, Internal medicine (Tokyo, Japan), 49:2371-2377, 2010年08月
Down-regulation of hepcidin resulting from long-term treatment with an anti-IL-6 receptor antibody (tocilizumab) improves anemia of inflammation in multicentric Castleman disease, (S.Nakazawa J.Song), N.Tomosugi, H.Kawabata, T.Ishikawa, T.Nishikawa, K.Yoshizaki, Blood., 116:3627-3634, 2010年07月
Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin, (S.Kono), K.Yoshida, N.Tomosugi, T.Terada, Y.Hamaya, S.Kanaoka, H.Mitajima, Biochimica et biophysica acta-molecular and cell biology of lipids, 1802:968-975, 2010年07月
鉄代謝の臨床 鉄欠乏と鉄過剰：診断と治療の進歩 ヘプシジンの発見とその後の発展, 友杉直久, 日本内科学会雑誌, 99:1180-1187, 2010年06月
Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders, (Y.Kaneko), H.Miyajima, A.Piperno, N.Tomosugi, H.Hayashi, N.Morotomi, K.Tsuchida, T.Ikeda, A.Ishikawa, Y.Ota, S.Wakusawa, K.Yoshioka, S.Kono, S.Pelucchi, A.Hattori, Y.Tatsumi, T.Okada, M.Yamagishi, Journal of gastroenterology., 45:1163-1171, 2010年06月
特集 鉄過敏症-その病態と治療 ヘプシジン測定, 友杉直久, 日本医師会雑誌, 139:290, 2010年05月
Tocilizumab, a humanized anti-interleukin-6 receptor antibody, improved anemia in monkey arthritis by suppressing IL-6-inducued hepcidin production., (M.Hashizume), Y.Uchiyama, N.Horai, N.Tomosugi, M.Mihara, Rheumatology international, 30:917-923, 2010年05月
Iron regulatory hormone hepcidin decreases in chronic heart failure patients with anemia, (M.Matsumoto), T.Tsujino, Masaaki Lee-Kawabata, Y.Naito, H.Akahori, T.Sakoda, M.Ohyanagi, N.Tomosugi, T.Masuyama, Circulation journal : official journal of the Japanese Circulation Society, 74:301-306, 2010年02月
Induction of HITS, a newly identified family with sequence similarity 107 protein (FAM107B), in cancer cells by heat shock stimulation, H.Nakajima, Y.Ishigaki, QI-S.Xia, T.Ikeda, Y.Yoshitake, H.Yonekura, T.Nojima, T.Tanaka, H.Umehara, N.Tomosugi, T.Takata, T.Shimasaki, N.Nakaya, I.Sato, K.Kawakami, K.Koizumi, T.Minamoto, Y.Motoo, International journal of oncology, 37:583-593, 2010年
基礎生物学研究所大型スペクトログラフ, 石垣靖人, 高田尊信, 友杉直久, 竹上 勉, 中川秀昭, 日本レーザー治療学会誌, 8:15-18, 2009年12月
ヘプシジン-25と骨髄造血機能, 友杉直久, 日本透析医学会雑誌, 42:821-822, 2009年11月
第21回腎と脂質研究会 腎移植レシピエントの推定糸球体濾過量（eGFR)と影響因子の検討（第1報）, 足立浩樹, 木村庄吾, 渥美浩克, 井村淳子, 山谷秀喜, 浅香充宏, 友杉直久, 横山 仁, Therapeutic Research, 30:1413-1414, 2009年10月
ヘプシジン-フェロポルチン系による鉄代謝制御機構, 友杉直久, 金沢大学十全医学会雑誌, 118:61-62, 2009年06月
【貧血治療の新時代】ヘプシジン, 友杉直久, 透析患者の合併症とその対策, 18：73-82, 2009年03月
Isolation of N-acetylneuraminic acid and N-glycolylneuraminic acid from Pleurocybella porrigens., T.Takata, T.Hasegawa, T.Tatsuno, J.Date, Y.Ishigaki, Y.Nakamura, N.Tomosugi, F.Takano, T.Ohta, Journal of health science (Tokyo, Japan), 55：373-379, 2009年03月
当院における過去30年間のループス糸球体腎炎の臨床病理学的検討, 奥山 宏, 木村庄吾, 渥美浩克, 井村淳子, 藤本圭司, 近澤芳寛, 中川 卓, 今村秀嗣, 山谷秀喜, 浅香充宏, 友杉直久, 横山 仁, 日本腎臓学会誌, 51：44-50, 2009年01月
エイジングの生物学 加齢に伴う蛋白質の変化, 友杉直久, アンチ・エイジング医学, 5:878-882, 2009年
Serum hepcidin-20 is elevated during the acute phase of myocardial infarction, (H.Suzuki), K.Toba, K.Kato, T.Ozawa, N.Tomosugi, M.Higuchi, T.Kusuyama, Y.Iso, N.Kobayashi, S.Yokoyama, N.Fukuda, H.Saitoh, K.Akazawa, Y.Aizawa, The Tohoku journal of experimental medicine., 218：93-98, 2009年
Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization, (JJ.Kroot), EH.J.M.Kemna, SS.Bansal, M.Busbridge, N.Campostrini, D.Girelli, RC.Hider, V.Koliaraki, A.Mamalaki, G.Olbina, N.Tomosugi, C.Tselepis, DG.Ward, T.Ganz, JC.M.Hendriks, DW.Swinkels, Haematologica, 94:1748-1752, 2009年
Oncostatin M and leukemia inhibitory factor increase hepcidin expression in hepatoma cell lines, (J.Kanda), T.Uchiyama, N.Tomosugi, M.Higuchi, T.Uchiyama, H.Kawabata, International journal of hematology., 90:545-552, 2009年
Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma, (T.Kamai), N.Tomosugi, H.Abe, K.Arai, K.Yoshida, BMC cancer [electronic resource]., 0.5625, 2009年
Impaired regulation of serum hepcidin during phlebotomy in patients with chronic hepatitis C, (R.Sugimoto), N.Fujita, N.Tomosugi, H.Miyauchi, H.Tanaka, M.Takeo, N.Nakagawa, M.Iwasa, Y.Kobayashi, M.Kaito, Y.Takei, Hepatology research : the official journal of the Japan Society of Hepatology, 39：619-624, 2009年
Clinical significance of serum hepcidin levels on early infectious complications in allogeneic hematopoietic stem cell transplantation, (J.Kanda), C.Mizumoto, H.Kawabata, T.Ichinohe, H.Tsuchida, N.Tomosugi, K.Matsuo, K.Yamashita, T.Kondo, T.Ishikawa, T.Uchiyama, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 15:956-962, 2009年
The liquid culture filtrates of entomogenous fungus Paecilomyces tenuipes and its glycoprotein constituent protects against anemia in mice treated with 5-fluorouracil, (T.Takata), T.Taanaka, N.Yahagi, R.Yahagi, H.Tsuchida, Y.Ishigaki, N.Tomosugi, S.Fushiya, F.Takano, T. Ohta, Biological & pharmaceutical bulletin, 31:1565-1573, 2008年08月
The Liquid Culture of Entomogenous fungus Paecilomyces tenuipes and Its Glycoprotein Costituent Protects against Anemia in Mice Treated with 5-fluorouracil., T.Takata, T. Tanaka, N. Yahagi, R. Yahagi, H. Tsuchida, Y.Ishigaki, N.Tomosugi, S. Fushiya, F. Takano, T. Ohta, Biological & pharmaceutical bulletin, 31 : 1561-1573, 2008年08月
移植拒否反応のプロテオミクス, 友杉直久, 臨床検査, 52:809-812, 2008年07月
Expression of hepcidin mRNA is uniformly suppressed in hepatocellular carcinoma, (H.Kijima), T.Sawada, N.Tomosugi, K.Kubota, BMC cancer [electronic resource]., 0.449305556, 2008年06月
先天性アンチトロンビンⅢ欠乏症を合併した維持透析患者に対する全身麻酔下手術の経験, (鈴木裕子), 伊藤文夫, 中澤速和, 前田佳子, 吉田一彦, 巴 ひかる, 友杉直久, 日本透析医学会雑誌, 41:641-645, 2008年
Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantaion, (J.Kanda), C.Mizumoto, H.Kawabata, H.Tsuchida, N.Tomosugi, K.Matsuo, T.Uchiyama, Haematologica, 93:1550-1554, 2008年
Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion, (N.Fujita), R.Sugimoto, S.Motonishi, N.Tomosugi, H.Tanaka, M.Takeo, M.Iwasa, Y.Kobayashi, H.Hayashi, M.Kaito, Y.Takei, Journal of hepatology, 49:702-710, 2008年
C型慢性肝炎における活性型 hepcidin(hepcidin25) の役割, (林 和彦), 片野義明, 石上雅敏, 中野 功, 後藤秀実, 涌澤伸哉, 林 久男, 友杉直久, 消化器科, 46:204-208, 2008年
臨床と研究 血液透析患者の鉄の至適指標は低フェリチン高TSAT－血清hepcidin、血清ferritin、TSATから－, (前田貞亮), 村上辰和嘉, 友杉直久, 日本透析医会雑誌, 22:242-249, 2007年08月
Anti-interleukin 6 receptor antibody tocilizumab reduces the level of serum hepcidin in patients with multicentric Castleman's disease, (H.Kawabata), N.Tomosugi, J.Kanda, Y.Tanaka, K.Yoshizaki, T.Uchiyama, Haematologica, 92:857-858, 2007年06月
臨床検査医学 Hepcidin による鉄代謝の制御 －臨床への応用, 友杉直久, 医学のあゆみ, 221:250-251, 2007年04月
鉄剤補充の方法, (前田貞亮), 友杉直久, 透析フロンティア, 17:14-20, 2007年
総論 鉄代謝をめぐる新しい知見, 友杉直久, 透析フロンティア, 17:2-8, 2007年
プロテインチップシステム(SELDI法)の臨床への応用－ヘプシジンのモニタリングによる鉄制御機構の把握－, 友杉直久, 日本透析医会雑誌, 104-111, 2007年
Ⅰ適正血液透析とエビデンス（７）貧血, 友杉直久, 臨床透析, 23:1555-1562, 2007年
hepcidin： 血液透析患者における鉄代謝制御因子, 友杉直久, 石川 勲, 日本透析医会雑誌, 21:316-321, 2006年08月
Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System, N.Tomosugi, H.Kawabata, R.Wakatabe, M.Higuchi, H.Yamaya, H.Umehara, I.Ishikawa, Blood., 108:1381-1387, 2006年08月
Proteomic analysis of serum, outflow dialysate and adsorbed protein onto dialysis membranes (polysulfone and PMMA) during hemodialysis treatment using SELDI-TOF-MS, I.Ishikawa, Y.Chikazawa, K.Sato, M.Nakagawa, H.Imamura, S.Hayama, H.Yamaya, M.Asaka, N.Tomosugi, H.Yokoyama, K.Matsumoto, American journal of nephrology, 26:372-380, 2006年06月
涙の蛋白質とシェーグレン症候群 プロテオミクス技術を用いた非侵襲的診断法の開発, 友杉直久, 北川和子, 検査と技術, 34:397-399, 2006年04月
Proteomic analysis of rat plasma by SELDI-TOF-MS under the condition of prevention of progressive adriamycin nephropathy using oral adsorbent AST-120, I.Ishikawa, T.Hayama, S.Yoshida, M.Asaka, N.Tomosugi, M.Watanabe, H.Yamato, M.Sugano, Nephron. Physiology, 103:125-130, 2006年
30年間における腎移植260例の経験, 石川 勲, 近澤芳寛, 佐藤一賢, 奥山 宏, 今村秀嗣, 羽山智之, 山谷秀喜, 浅香充宏, 友杉直久, 由利健久, 鈴木孝治, 田中達朗, 金沢医科大学雑誌, 30:522-530, 2005年12月
腹膜透析中止後7年目に発症した被嚢性腹膜硬化症の1例, 羽山智之, 佐藤一賢, 近澤芳寛, 今村秀嗣, 奥山 宏, 山谷秀喜, 浅香充宏, 友杉直久, 石川 勲, 腎と透析, 59：1055-1059, 2005年
研究施設紹介 LABORATORY 2005金沢医科大学腎機能治療学（腎臓内科）, 石川 勲, 由利健久, 友杉直久, 浅香充宏, 山谷秀喜, 羽山智之, 今村秀嗣, 奥山 宏, 佐藤一賢, 近澤芳寛, Nephrology Frontier, 297-300, 2005年
急性腎不全で発症した腎限局性サルコイドーシスの1例, 足立浩樹, 浅香充宏, 佐藤一賢, 中川 卓, 森田恭子, 羽山智之, 山谷秀喜, 友杉直久, 由利健久, 石川 勲, 腎と透析, 58：237-240, 2005年
Hepcidinー最近の進歩, 川端 浩, 河南崇典, 友杉直久, 石川 勲, 梅原久範, 血液・腫瘍科, 51:174-182, 2005年
Diagnostic potential of tear proteomic patterns in Sjogren`s syndrome, N.Tomosugi, K.Kitagawa, N.Takahashi, S.Sugai, I.Ishikawa, Journal of proteome research., 4:820-825, 2005年
移植腎に発症したBKウイルス腎症の１例, 羽山智之, 足立浩樹, 佐藤一賢, 中川 卓, 森田恭子, 山谷秀喜, 浅香充宏, 友杉直久, 由利健久, 石川 勲, 移植, 39：92-97, 2004年
Twenty-year follow-up of acquired renal cystic disease, I. Ishikawa, Y. Saito, M. Asaka, N. Tomosugi, T. Yuri, M. Watanabe, *R. Honda, Clinical nephrology., 59: 153-159, 2003年
Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury, (K. Furuichi), N. Tomosugi, et al., Journal of the American Society of Nephrology : JASN., 14: 1066-1071, 2003年
Cystic renal cell carcinoma, suspected because of lack of regression of renal cysts after renal transplantation in a dialysis patient with acquired renal cystic disease, I. Ishikawa, A. Saito, Y. Chikazawa, M. Asaka, N. Tomosugi, T. Yuri, *K. Suzuki, *Y. Ueda, *M. Ozaki, Clinical and experimental nephrology, 7: 81-84, 2003年
高Ca血症と高度の腎機能障害を呈した腎サルコイドーシスの１例, 斎藤淳史, 近澤芳寛, 今村秀嗣, 奥山 宏, 山谷秀喜, 中澤哲也, 浅香充宏, 友杉直久, 由利健久, 石川 勲, Clinical Calcium, 12: 396-400, 2002年
Dynamic CTスキャンで梗塞部皮質の造影がみられた左腎梗塞の１例, 高橋由夏, 中川 卓, 今村秀嗣, 奥山 宏, 羽山智之, 渡邊将隆, 中澤哲也, 浅香充宏, 友杉直久, 由利健久, 石川 勲, 金沢医科大学雑誌, 27: 137-142, 2002年
経過中に腹部大動脈血栓を併発し, 両側下肢切断に至ったネフローゼ症候群の1例, 今村秀嗣, 浅香充宏, 齋藤淳史, 奥山 宏, 渡邉将隆, 中澤哲也, 友杉直久, 由利健久, 石川 勲, 日本腎臓学会誌, 43: 608-612, 2001年
発熱と腹痛をきたした血液透析患者の1例, 浅香充宏, 近本恵美子, 友杉直久, 石川 勲, 臨床透析, 16:2161-2168, 2000年
Hemolytic uremic syndrome associated with influenza A virus infection in an adult renal allograft recipient: case report and review of the literature, M.Asaka, I.Ishikawa, T.Nakazawa, N.Tomosugi, T.Yuri, *K.Suzuki, Nephron., 84:258-266, 2000年
Digital glomerular reconstruction in a patient with a sporadic adult form of glomerulocystic kidney disease, J.S.Liu, I.Ishikawa, Y.Saito, T.Nakazawa, N.Tomosugi, *Y.Ishikawa, American journal of kidney diseases : the official journal of the National Kidney Foundation., 35:216-220, 2000年
Acute glomerulonephritis after human parvovirus B19 infection, T.Nakazawa, N.Tomosugi, K.Sakamoto, M.Asaka, T.Yuri, I.Ishikawa, *S.Kitagawa, American journal of kidney diseases : the official journal of the National Kidney Foundation., 35:E1-8, 2000年
Clinical evaluation of relative hypoparathyroidism in uremia: Continuous suppression of parathyroid hormone secretion without hypercalcemia in patients with diabetes mellitus and advanced age, Asaka M, Ishikawa I, Nakazawa T, Tomosugi N, Yuri T, Fukuda Y, Kanazawa Ika Daigaku zasshi = Journal of Kanazawa Medical University. Links , 23: 38-45, 1998年
Fifteen-year follow-up of acquired renal cystic disease-A gender difference., Ishikawa I, Saito Y, Nakamura M, Takada K, Ishii H, Nakazawa T, Fukuda Y, Asaka M, Tomosugi N, Yuri T, Nephron., 75: 315-320, 1997年
Activation of metalloproteinase-2 by membrane type metalloproteinase expressed on human mesangial cell membrane., Tomosugi N, Yamaya H, Yuri T, Nakamura M, Nakazawa T, Asaka M, Ishikawa I, Contrib Nephrol, 118: 135-140, 1996年
Protective Effects of Collagen Tripeptides in Human Aortic Endothelial Cells by Restoring ROS-Induced Transcriptional Repression, Hidehito Saito-Takatsuji, Yasuo Yoshitomi, Yasuhito Ishigaki, Shoko Yamamoto, Noriaki Numata, Yasuo Sakai, Masayoshi Takeuchi, Naohisa Tomosugi, Shogo Katuda, hideto Yonekura, Takayuki Ikeda, Nutrients, 13:2226, 2021年06月
Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa, (Chie Ogawa), Ken Tsuchiya, Naohisa Tomosugi, Kunimi Maeda, PLOS ONE, 16:e0252439, 2021年06月
Erythropoiesis stimulating agents are associated with serum fibroblast growth factor 23 metabolism in patients on hemodialysis, (Hirokazu Honda), Kenji Tanaka ,Tetsuo Michihata , Keigo Shibagaki ,Toshitaka Yuza, Keiichi Hirao, Naohisa Tomosugi, Tomas Ganz, Yuichiro Higashimoto, Clinical Kidney Journal, 4:943-949, 2021年03月
Novel Platform for Regulation of Extracellular Vesicles and Metabolites Secretion from Cells Using a Multi-Linkable Horizontal Co-Culture Plate, Shimasaki T, Yamamoto S, Omura R, Ito K, Nishide Y, Yamada H, Ohtomo K, Ishisaka T, Okano K, Ogawa T, Tsuji H, Matsuo Y, Minamoto T, Tomosugi N, Ferain E, Ochiya T., micromachines, 12:1431, 2021年11月
Comprehensive analysis of protein-expression changes specific to immunoglobulin G4-related disease, Takafumi Kawanami, Haruka Kawanami-Iwao, Takanobu Takata, Yasuhito Ishigaki, Naohisa Tomosugi, Tsutomu Takegami, Hiroto Yanagisawa, Shino Fujimoto, Tomoyuki Sakai, Yoshimasa Fujita, Kazunori Yamada, Shuichi Mizuta, Hiroshi Kawabata, Toshihiro Fukushima, Yuko Hirose, Yasufumi Masaki, Clinica Chimica Acta, 523:45-57, 2021年
